The National Stem Cell Bank, housed at the WiCell Research Institute in Madison, has received two more embryonic stem-cell lines, giving it all 21 lines approved for federal funding by the Bush administration.
The two new lines are from Cellartis, a biotechnology company in Sweden, WiCell announced Monday.